Vaccines broader value advisory board
On the 11th of November Pfizer organized an advisory board on the broader value of vaccines. Experts of the field were invited to provide feedback on the broader benefits of vaccines and how to apply to HTA assessment to ensure full value of vaccines has been captured.
During the meeting, the different frameworks available and the usefulness of these frameworks for decision making were also discussed. Inge van der Putten was invited to give her expert opinion based on her findings on the PhD thesis: Using information on the broader economic impact of vaccines in evidence-informed decision making.
Also read
-
Carlos Mota develops new in vitro models to study kidney diseases at MERLN. For his NEPRHON project, he received the ERC Consolidator Grant.
-
Julien was admitted at the last second for the Medicine bachelor. A turning point that led him to research perihilar cholangiocarcinoma, a rare and specific type of bile duct cancer at MUMC+.
-
Two researchers from Maastricht University (UM) have received a prestigious ERC Consolidator Grant from the European Research Council. This will allow them to set up a scientific research team in the coming years for studies on bioprinted models of a human kidney and on female guest workers from southern Europe who came to north-western Europe in the second half of the 20th century.
